Advertisement

Fruquintinib + Paclitaxel Aids Advanced Gastric/Gastroesophageal Junction Cancer

0

Improvement seen in progression-free survival among patients who had disease progression on first-line chemotherapy

NASH Resolution Increased, Improvement of Fibrosis Seen With Resmetirom

0

Resmetirom 80 mg and 100 mg better than placebo for patients with NASH and fibrosis stage F1B, F2, F3

CDC Investigating Illness Outbreak on Luxury Cruise Ship

0
By Robin Foster HealthDay Reporter THURSDAY, Feb. 8, 2024 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention is investigating an outbreak of...

BP Control Improved With Gastric Bypass in Patients With Obesity, Hypertension

0

Significantly higher rate seen for number of medications with at least a 30 percent reduction

Price of Prescription Drugs Almost Threefold Higher in the United States

0

U.S. prices for brand-name originator drugs 422 percent higher; price of unbranded generics 67 percent of comparison countries

Rate of Venous Thromboembolism Increased With Cancer Surgery

0

Cause-specific hazard ratio for pulmonary embolism peaked after discharge, then plateaued 60 to 90 days later

Missed, Undiagnosed Cirrhosis May Be Risk Factor for Cognitive Decline

0

More than 5 percent of veterans with dementia had Fibrosis-4 score greater than 3.25, suggestive of cirrhosis

Bariatric Surgeries Carry Low Perioperative Risks

0

Similar outcomes seen for laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass

Overall Decline in Cancer Deaths Expected in Europe in 2024

0

However, experts predict rise in colorectal cancer deaths in younger adults

High-Quality Diet at 1 Year of Age Tied to Lower Risk for IBD

0

Specific risk reduction seen with higher vegetable and fish intake at 1 year of age